Related Experiment Video

Updated: Jul 1, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

mTOR, cancer and transplantation

Edward K Geissler1, Hans J Schlitt, George Thomas

  • 1Department for Surgery, University of Regensburg, Regensburg, Germany. edward.geissler@klinik.uni-regensburg.de

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|September 13, 2008
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell growth and is crucial in organ transplantation. Understanding mTOR signaling can help manage immune responses and prevent cancer in transplant recipients.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology
  • Transplantation Medicine

Background:

  • The mammalian target of rapamycin (mTOR) pathway is a key regulator of cellular processes, including growth, proliferation, and survival.
  • Dysregulation of the mTOR pathway is implicated in both cancer progression and immune responses, making it a critical target in organ transplantation.

Purpose of the Study:

  • To review the latest molecular developments in mTOR signaling.
  • To explore the potential of pharmacologic mTOR intervention in managing transplant recipients.
  • To balance long-term antidonor immune responses and the risk of malignancy.

Main Methods:

  • Literature review of current research on mTOR signaling pathways.
  • Analysis of the role of mTOR in T cell IL-2 signaling and alloimmune reactivity.
  • Examination of mTOR's involvement in neoplastic cell activation and cancer development.

Main Results:

  • The mTOR pathway controls vital cellular functions, influencing immune reactivity and cancer progression.
  • mTOR activity blockade can inhibit T cell signaling, impacting alloimmune responses.
  • Constitutive activation of mTOR is frequently observed in cancer cells.

Conclusions:

  • A comprehensive understanding of mTOR signaling is essential for organ transplant recipients.
  • Pharmacologic modulation of mTOR may offer a strategy to mitigate risks of allograft rejection and cancer development.
  • Targeting mTOR presents a potential therapeutic approach to improve long-term outcomes in transplantation.

More Related Videos

Murine Full-thickness Skin Transplantation07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.